Jean-Paul Kress
CIK: 0001654979
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vor Biopharma Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 5, 2025VOR
Vor Biopharma Inc.
Disposition(D)DirectEmployee Stock Option (right to buy)
4.2M shares- - Dec 5, 2025VOR
Vor Biopharma Inc.
Award(A)DirectEmployee Stock Option (right to buy)
4.2M shares- - Jun 26, 2025VOR
Vor Biopharma Inc.
Award(A)DirectEmployee Stock Option (right to buy)
83.3M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 5, 2025 | VOR Vor Biopharma Inc. | Disposition(D) Employee Stock Option (right to buy) | 4,164,831 | - | - | Direct |
| Dec 5, 2025 | VOR Vor Biopharma Inc. | Award(A) Employee Stock Option (right to buy) | 4,164,831 | - | - | Direct |
| Jun 26, 2025 | VOR Vor Biopharma Inc. | Award(A) Employee Stock Option (right to buy) | 83,296,638 | - | - | Direct |
1-3 of 3 transactions
About Kress Jean-Paul
Kress Jean-Paul (SEC CIK 0001654979) files insider reports with the SEC as CEO and Chairman of Vor Biopharma Inc. (VOR).
Signal8 holds 3 ownership filings by Kress Jean-Paul (1 Form 3, 2 Form 4), filed between Jun 27, 2025 and Dec 9, 2025. Those filings report 3 transactions, from Jun 26, 2025 to Dec 5, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kress Jean-Paul's filings is in CAMBRIDGE, MA.
Recent filings by Kress Jean-Paul
Other insiders filing for Vor Biopharma Inc. (VOR)
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- ZACCARDELLI DAVID, Director
- Detheux Michel, Director
- Namouni Fouad, Director
- Joustra Wouter, Director
- Kalir Erez, Director